These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

174 related articles for article (PubMed ID: 23668999)

  • 41. The expression and clinical significance of TGF-beta1 and MMP2 in human renal clear cell carcinoma.
    Yang SD; Sun RC; Mu HJ; Xu ZQ; Zhou ZY
    Int J Surg Pathol; 2010 Apr; 18(2):85-93. PubMed ID: 19223381
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Phosphorylation of ERK1/2 and prognosis of clear cell renal cell carcinoma.
    Lee HJ; Kim DI; Kang GH; Kwak C; Ku JH; Moon KC
    Urology; 2009 Feb; 73(2):394-9. PubMed ID: 18849062
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Tumoral epithelial and stromal expression of SMAD proteins in pancreatic ductal adenocarcinomas.
    Handra-Luca A; Hammel P; Sauvanet A; Ruszniewski P; Couvelard A
    J Hepatobiliary Pancreat Sci; 2013 Mar; 20(3):294-302. PubMed ID: 22581056
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Significance of nuclear grade and tumor size in Korean patients with chromophobe renal cell carcinoma: a comparison with conventional renal cell carcinoma.
    Ku JH; Moon KC; Kwak C; Kim HH
    Urol Oncol; 2011; 29(5):487-91. PubMed ID: 19767221
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Prognostic prediction in patients with metastatic renal cell carcinoma treated with sorafenib based on expression levels of potential molecular markers in radical nephrectomy specimens.
    Kusuda Y; Miyake H; Behnsawy HM; Fukuhara T; Inoue TA; Fujisawa M
    Urol Oncol; 2013 Jan; 31(1):42-50. PubMed ID: 21396851
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Expression of bone morphogenetic proteins, the subfamily of the transforming growth factor-beta superfamily, in renal cell carcinoma.
    Kwak C; Park YH; Kim IY; Moon KC; Ku JH
    J Urol; 2007 Sep; 178(3 Pt 1):1062-7. PubMed ID: 17644140
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Cumulative number of altered biomarkers in mammalian target of rapamycin pathway is an independent predictor of outcome in patients with clear cell renal cell carcinoma.
    Darwish OM; Kapur P; Youssef RF; Bagrodia A; Belsante M; Alhalabi F; Sagalowsky AI; Lotan Y; Margulis V
    Urology; 2013 Mar; 81(3):581-6. PubMed ID: 23290145
    [TBL] [Abstract][Full Text] [Related]  

  • 48. The influence of pNx/pN0 grouping in a multivariate setting for outcome modeling in patients with clear cell renal cell carcinoma.
    Ward JF; Blute ML; Cheville JC; Lohse CM; Weaver AL; Zincke H
    J Urol; 2002 Jul; 168(1):56-60. PubMed ID: 12050492
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Expression of matrix metalloproteinase-7 on cancer cells and tissue endothelial cells in renal cell carcinoma: prognostic implications and clinical significance for invasion and metastasis.
    Miyata Y; Iwata T; Ohba K; Kanda S; Nishikido M; Kanetake H
    Clin Cancer Res; 2006 Dec; 12(23):6998-7003. PubMed ID: 17145820
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Percentage of high-grade carcinoma as a prognostic indicator in patients with renal cell carcinoma.
    Serrano MF; Katz M; Yan Y; Kibel AS; Humphrey PA
    Cancer; 2008 Aug; 113(3):477-83. PubMed ID: 18484589
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Loss of caspase 7 expression is associated with poor prognosis in renal cell carcinoma clear cell subtype.
    Vilella-Arias SA; Rocha RM; da Costa WH; Zequi Sde C; Guimarães GC; Verjovski-Almeida S; Soares FA; Reis EM
    Urology; 2013 Oct; 82(4):974.e1-7. PubMed ID: 23920448
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Serum insulin-like growth factor-1 is an independent predictor of prognosis in patients with renal cell carcinoma.
    Rasmuson T; Grankvist K; Jacobsen J; Olsson T; Ljungberg B
    Acta Oncol; 2004; 43(8):744-8. PubMed ID: 15764220
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Volume-weighted mean nuclear volume as a prognostic factor in renal cell carcinoma.
    Soda T; Fujikawa K; Ito T; Sasaki M; Nishio Y; Miyakawa M
    Lab Invest; 1999 Jul; 79(7):859-67. PubMed ID: 10418826
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Profilin-1 expression is associated with high grade and stage and decreased disease-free survival in renal cell carcinoma.
    Karamchandani JR; Gabril MY; Ibrahim R; Scorilas A; Filter E; Finelli A; Lee JY; Ordon M; Pasic M; Romaschin AD; Yousef GM
    Hum Pathol; 2015 May; 46(5):673-80. PubMed ID: 25704627
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Cytoplasmic PAR-3 protein expression is associated with adverse prognostic factors in clear cell renal cell carcinoma and independently impacts survival.
    Dagher J; Dugay F; Rioux-Leclercq N; Verhoest G; Oger E; Bensalah K; Cabillic F; Jouan F; Kammerer-Jacquet SF; Fergelot P; Vigneau C; Arlot-Bonnemains Y; Belaud-Rotureau MA
    Hum Pathol; 2014 Aug; 45(8):1639-46. PubMed ID: 24856572
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Factor-inhibiting hypoxia-inducible factor expression in patients with high-risk locally advanced renal cell carcinoma and its relationship with tumor progression.
    Deng S; Zhang P; Zeng H; Wang W; Jin T; Wang J; Dong Q
    Kaohsiung J Med Sci; 2014 Jan; 30(1):12-9. PubMed ID: 24388053
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Expression of CD9 and CD82 in clear cell renal cell carcinoma and its clinical significance.
    Kwon HJ; Min SY; Park MJ; Lee C; Park JH; Chae JY; Moon KC
    Pathol Res Pract; 2014 May; 210(5):285-90. PubMed ID: 24553302
    [TBL] [Abstract][Full Text] [Related]  

  • 58. DHH is an independent prognosticator of oncologic outcome of clear cell renal cell carcinoma.
    Jäger W; Thomas C; Fazli L; Hurtado-Coll A; Li E; Janssen C; Gust KM; So AI; Hainz M; Schmidtmann I; Roos FC; Thüroff JW; Brenner W; Black PC
    J Urol; 2014 Dec; 192(6):1842-8. PubMed ID: 25046620
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Decreased PBRM1 expression predicts unfavorable prognosis in patients with clear cell renal cell carcinoma.
    Nam SJ; Lee C; Park JH; Moon KC
    Urol Oncol; 2015 Aug; 33(8):340.e9-16. PubMed ID: 26003625
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Nuclear expression and clinical significance of phosphohistidine phosphatase 1 in clear-cell renal cell carcinoma.
    Shen H; Yang P; Liu Q; Tian Y
    J Int Med Res; 2015 Dec; 43(6):747-57. PubMed ID: 26537769
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.